Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of unsaturated sphingosine compounds as chemotherapeutic agents for the treatment of cancer

Use of unsaturated sphingosine compounds as chemotherapeutic agents for the treatment of cancer

US Patent 9133097 · Granted Sep 15, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered CO2-fixing chemotrophic microorganisms producing carbon-based product2018
Methods of using natural and engineered organisms to produce small molecules for2017
Caged ceramide-1-phosphate derivatives2016
Use of unsaturated sphingosine compounds as chemotherapeutic agents for the trea2014
Use of unsaturated sphingosine compounds as chemotherapeutic agents for the trea2014
Use of unsaturated sphingosine compounds as chemotherapeutic agents for the trea2014
Boron dipyrromethene difluoro (BODIPY) conjugates2012
Non-natural sphingolipid analogs and uses thereof2012
Synthesis of glycerolipid carbamates and dicarbamates and their use as an antitu2012
Immunomodulation by altering sphingosine 1-phosphate lyase (SPL) activity2012
Free cholesterol analogs bearing a boron dipyrromethene difluoro (BODIPY) fluoro2011
Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agent2011